Mark Cuban recently issued a challenge to individual investors regarding their retirement portfolios. He claims that if your 401(k) or index funds hold shares in major health insurance companies, you are indirectly contributing to the rising costs of American healthcare. Cuban asserts these firms prioritize share price over patient care, frequently utilizing delay and denial tactics that impact medical outcomes.
The scale of this issue is significant. Statistics show that roughly 62 percent of Americans own stocks, often through broad index funds like those offered by Vanguard. These funds frequently bundle positions in large insurers such as UnitedHealth Group, CVS Health, and Cigna. Cuban suggests investors contact their fund managers to demand divestment from these specific carriers as a way to align financial holdings with personal values.
Industry participants maintain a different perspective on these dynamics. Large insurers argue that their scale allows for negotiated discounts that keep premiums lower than they would be otherwise. Data shows that in 2025, UnitedHealth Group reported billions in negotiated savings for customers. Meanwhile, the Federal Trade Commission has scrutinized the role of drug benefit managers, identifying high markups on prescription drugs that contribute to the current financial burden on families.
Investors looking to change their portfolio composition have several avenues. Many providers now offer specific environmental, social, and governance portfolios that exclude certain industries. Others might consider diversifying into assets like precious metals or real estate-backed credit to reduce exposure to public equities while seeking different income streams. Consulting a fiduciary advisor is a recommended step to understand the potential tax consequences of selling current positions or moving assets to new funds.